Work Area: IP public policy

Latest content

Global patent community waking up to potential UPC impact

IAM Q2 panel report reveals growing awareness of new European patent system’s strategic significance

26 September 2022

Reform of Section 101 should be part of US government technology policy

Saturday Opinion: Without a coherent approach to capturing domestic value from R&D including greater clarity on subject matter patentability, the positive consequences of higher US government funding will be felt as much in Berlin, Bangalore and Beijing as Boston

24 September 2022

USPTO director Kathi Vidal is wielding review authority to change policy on discretionary denials

Despite her caution against reading too much into her rulings, PTAB practitioners are noting patterns and predicting their significance

23 September 2022

As the US mid-term elections near, some wonder whether the Senate’s IP sub-committee will survive

With the retirement of Patrick Leahy and the overall race too close to call, uncertainty is the name of the game in Washington DC

14 September 2022

Asia, US IP office leaders look to keep apace with AI and NFTs

Patent bodies must adapt and evolve to address knowledge gaps in changing digital landscape

09 September 2022

USPTO director seeks to drive US patent standards participation

Kathi Vidal says the agency is working with NIST and the Biden administration to build strategies that will lead to greater involvement

07 September 2022

Moderna is likely regretting its covid-19 patent pledge

The company’s October 2020 non-enforcement promise may be a roadblock for its legal action against Pfizer/BioNTech

03 September 2022

The dangers of patent counting to assess technology leadership

Former USPTO Director Andrei Iancu warns that the US is facing “a new Sputnik moment”, but he and others at an online event caution against reading too much into raw numbers

01 September 2022

Allergan scores victory in trailblazing US patent fraud whistle-blower suit

Ninth Circuit Court of Appeal puts the breaks on whistleblower’s attempts to show deception in company’s dealings with the USPTO

01 September 2022

Why the new CHIPS + Science Act matters for IP

Although many provisions were stripped out of the final version of the legislation, it still contains important tech transfer-related elements, while the huge sums for R&D it envisages are almost certain to spawn more patents

30 August 2022

• <
• 1
• ...
• 2
• ...
• 7
• 8
• 9
• 10
• ...
• 11
• 12
• 13
• ...
• >